Joseph S D'Arrigo is an expert in Medical imaging at Cavitation-Control Technology (United States). Joseph S D'Arrigo has authored 32 publications, the most recent in 2020. SLR score: 95 (community average: 125). How the SLR is computed.

LeadR Profile

Joseph S D'Arrigo Cavitation-Control Technology United States
95 ScienceLeadR Reputation 95
Network Map

Medical imaging

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2017 - 2020

Source: PubMed

Cavitation-Control Technology

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 32

Citations

Citations: 818 1st author: 4 Last author: 5 Unique author: 15


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.
PMID 33307726 — cells, dementia, alzheimer disease, pharmaceutical preparations, brain, inflammasomes, covid-19, therapeutics, memory
Am J Alzheimers Dis Other Demen202016
Nanotargeting Dementia Etiology: Aiming Drug Nanocarriers Toward Receptors for Vascular Endothelium, Serum Amyloid A, Inflammasomes, and Oxidative Stress
OpenAlex W3134088787 — dementia, endothelium, vascular, serum, serum amyloid a protein, pharmaceutical preparations, stress, physiological, inflammasomes, oxidative stress, lipoproteins, hdl, therapeutics, amyloid, endothelium
Nano Progress20205
Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades.
PMID 32244941 — cells, dementia, biomimetics, blood, nanoparticles, pharmaceutical preparations, receptors, scavenger, oxidative stress, lipoproteins, hdl, apolipoproteins a, drug delivery systems, therapeutics, apolipoprotein a-i
Biomimetics (Basel)202015
Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium.
PMID 29274774 — cells, colloids, dementia, alzheimer disease, pharmaceutical preparations, microbubbles, dementia, vascular, therapeutics, chemistry, physical, endothelium
Adv Colloid Interface Sci201718
Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood⁻Brain Barrier.
PMID 31105226 — blood-brain barrier, cells, dementia, blood, pharmaceutical preparations, receptors, scavenger, brain, drug delivery systems, therapeutics
Biomimetics (Basel)20186

LeadR Networks

Main global connection map